CoaguChek XS System (HCP) The CoaguChek XS System is intended for use by professional healthcare providers for quantitative prothrombin time testing for the monitoring of warfarin therapy.
Published July 3, 2013 · Recall initiated: May 16, 2013
Summary
FDA records medical device Class II recall Z-1584-2013, published July 3, 2013 and initiated May 16, 2013. Recalling firm: Roche Diagnostics Operations, Inc.; Status: Terminated; Reported quantity: 86553 meters; Lot: Model/Catalog/Part Number: 04837975001 and 04625412160. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Roche has confirmed the potential for an undetected elevated INR test result with the CoaguChek XS, CoaguChek XS Plus, and CoaguChek XS Pro meters. In rare cases, instead of a value, an ERROR 6 message is displayed.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Roche Diagnostics Operations, Inc.
- Distributor
- Nationwide Distribution
- Lot
- Model/Catalog/Part Number: 04837975001 and 04625412160
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAcobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, inNovember 27, 2024
- FDACreatine Kinase (CK) used on cobas c 311/501/502 and COBAS INTEGRA 400 plus-In vitro test for the quantitativeOctober 2, 2024
- FDAAlbumin Gen.2, Catalog 05166861190October 21, 2020
- FDAElecsys Anti-HAV IgM assay-for the in vitro qualitative detection of IgM antibodies to hepatitis A virusDecember 18, 2019
- FDACoaguChek XS Plus System The CoaguChek XS Plus system for use by professional healthcare providers forJuly 3, 2013
- FDAThe Centricity Laboratory System is intended to be an information system designed to support the clinical andJuly 3, 2013
Questions about this recall
Was CoaguChek XS System (HCP) The CoaguChek XS System is intended for use by professional healthcare providers for quantitative prothrombin time testing for the monitoring of warfarin therapy. recalled?
Yes. FDA published recall Z-1584-2013 on July 3, 2013. Reported hazard: Roche has confirmed the potential for an undetected elevated INR test result with the CoaguChek XS, CoaguChek XS Plus, and CoaguChek XS Pro meters. In rare cases, instead of a value, an ERROR 6 message is displayed.
What should I do if I have this product?
Voluntary: Firm initiated · Letter